Impact of age on clinical outcomes among patients with hepatocellular carcinoma: A systematic review and meta-analysis

被引:0
作者
Bardhi, Olgert [1 ]
Daher, Darine [1 ]
Patel, Mausam [1 ]
El-Dahan, Karim Seif [1 ]
Rich, Nicole E. [1 ]
Mitta, Sukul [1 ]
Parikh, Neehar D. [2 ]
Pillai, Anjana [3 ]
Kulik, Laura M. [4 ]
Yang, Ju Dong [5 ]
Kulkarni, Anand V. [6 ]
Gopal, Purva [1 ]
Singal, Amit G. [1 ]
机构
[1] Univ Texas Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA
[2] Univ Michigan, Dept Internal Med, Ann Arbor, MI USA
[3] Univ Chicago, Dept Internal Med, Chicago, IL USA
[4] Northwestern Univ, Dept Internal Med, Evanston, IL USA
[5] Cedars Sinai Med Ctr, Dept Internal Med, Los Angeles, CA USA
[6] AIG Hosp, Dept Hepatol & Liver Transplantat, Hyderabad, India
关键词
Liver cancer; Elderly; Disparities; Prognosis; Treatment; LIVER-TRANSPLANTATION; COLORECTAL-CANCER; UNITED-STATES; SURVEILLANCE; SURVIVAL; OLDER; MANAGEMENT; RECIPIENTS; PROGNOSIS;
D O I
10.1016/j.jhepr.2025.101368
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Older adults have lower treatment eligibility and worse survival across cancer types; however, the association between age and outcomes in patients with hepatocellular carcinoma (HCC) has not been well characterized. Methods: We performed a search of the PubMed, Ovid MEDLINE, and EMBASE databases from January 2000 to July 2022 to identify studies reporting tumor stage, curative treatment, and overall survival among patients with HCC, stratified by age. Using the DerSimonian and Laird method for a random-effects model, we calculated pooled risk ratios (RRs) for curative treatment receipt and hazard ratios (HRs) for overall survival among younger and older patients (per age thresholds in each study). Results: We identified 103 studies (n = 154,152 patients) that reported outcomes in younger vs. older patients with HCC. Younger patients were more likely to undergo curative treatment (RR 1.48, 95% CI 1.24-1.77; I-2 = 99%), although few studies reported treatment among those with early-stage HCC. Younger patients had better survival than older patients (HR 0.87, 95% CI 0.83-0.92; I-2 = 89%), which was consistent in subgroups using age thresholds of <70 years (HR 0.94, 95% CI 0.89-0.99; I-2 = 78%) and <75 years (HR 0.83, 95% CI 0.70-0.98; I-2 = 79%). Younger patients also had better survival in studies of patients with early-stage HCC (HR 0.78, 95% CI 0.65-0.94; I-2 = 60%) and those undergoing curative therapy (HR 0.87, 95% CI 0.77-0.98; I-2 = 87%). Conclusions: Older patients with HCC are less likely to receive curative treatment and have worse survival than their younger counterparts. Studies to identify factors associated with worse prognosis can inform intervention targets. (c) 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:10
相关论文
共 45 条
[1]   An Assessment of Benefits and Harms of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis [J].
Atiq, Omair ;
Tiro, Jasmin ;
Yopp, Adam C. ;
Muffler, Adam ;
Marrero, Jorge A. ;
Parikh, Neehar D. ;
Murphy, Caitlin ;
McCallister, Katharine ;
Singal, Amit G. .
HEPATOLOGY, 2017, 65 (04) :1196-1205
[2]   Management and prognosis of hepatocellular carcinoma in the elderly: Results of an in-field multicenter cohort study [J].
Borzio, Mauro ;
Dionigi, Elena ;
Vitale, Alessandro ;
Rossini, Angelo ;
Marignani, Massimo ;
Fornari, Fabio ;
Vicari, Susanna ;
De Sio, Ilario ;
Farinati, Fabio ;
Bertolini, Emanuela ;
Oliveri, Filippo ;
Leandro, Gioacchino ;
Francica, Giampiero ;
Mitra, Mario ;
Omazzi, Barbara ;
Boccia, Sergio ;
Salmi, Andrea ;
Toldi, Anna ;
Sacco, Rodolfo .
LIVER INTERNATIONAL, 2017, 37 (08) :1184-1192
[3]   Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634
[4]   Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: A population-based study [J].
El-Serag, HB ;
Siegel, AB ;
Davila, JA ;
Shaib, YH ;
Cayton-Woody, M ;
McBride, R ;
McGlynn, KA .
JOURNAL OF HEPATOLOGY, 2006, 44 (01) :158-166
[5]  
European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019
[6]   How to Treat Hepatocellular Carcinoma in Elderly Patients [J].
Federico, Piera ;
Giunta, Emilio Francesco ;
Pappalardo, Annalisa ;
Tufo, Andrea ;
Marte, Gianpaolo ;
Attademo, Laura ;
Fabbrocini, Antonietta ;
Petrillo, Angelica ;
Daniele, Bruno .
PHARMACEUTICALS, 2021, 14 (03)
[7]   Survival benefit from liver transplantation for patients with and without hepatocellular carcinoma [J].
Goudsmit, Ben F. J. ;
Prosepe, Ilaria ;
Tushuizen, Maarten E. ;
Mazzaferro, Vincenzo ;
Alwayn, Ian P. J. ;
Hoek, Bart van ;
Braat, Andries E. ;
Putter, Hein .
JHEP REPORTS, 2023, 5 (12)
[8]   Hepatocellular carcinoma in elderly: Clinical characteristics, treatments and outcomes compared with younger adults [J].
Guo, Hui ;
Wu, Tao ;
Lu, Qiang ;
Dong, Jian ;
Ren, Yi-Fan ;
Nan, Ke-Jun ;
Lv, Yi ;
Zhang, Xu-Feng .
PLOS ONE, 2017, 12 (09)
[9]   Referral Patterns and Treatment Choices for Patients with Hepatocellular Carcinoma: A United States Population-Based Study [J].
Hyder, Omar ;
Dodson, Rebecca M. ;
Nathan, Hari ;
Herman, Joseph M. ;
Cosgrove, David ;
Kamel, Ihab ;
Geschwind, Jean-Francois H. ;
Pawlik, Timothy M. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (05) :896-906
[10]   AGA Clinical Practice Update on Risk Stratification for Colorectal Cancer Screening and Post-Polypectomy Surveillance: Expert Review [J].
Issaka, Rachel B. ;
Chan, Andrew T. ;
Gupta, Samir .
GASTROENTEROLOGY, 2023, 165 (05) :1280-1291